Rights and permissions
About this article
Cite this article
Bone mineral metabolism should be monitored carefully in patients receiving tacrolimus-based immunosuppression. React. Wkly. 710, 4 (1998). https://doi.org/10.2165/00128415-199807100-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-199807100-00007